Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × veliparib × 90 days × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 2 Breast Neoplasms 2 Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Hemangiosarcoma 1 Gliosarcoma 1 Glioblastoma 1 Ann Arbor Stage III Non-Hodgkin Lymphoma 1 Advanced Malignant Solid Neoplasm 1 Adenocarcinoma, Bronchiolo-Alveolar 1 Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 9 Vincristine 7 venetoclax 5 prednylidene 5 deltacortene 5 Prednisone 5 Doxorubicin 5 merphos 4 dexamethasone acetate 4 dexamethasone 21-phosphate 4 auricularum 4 Methotrexate 4 Granulocyte Colony-Stimulating Factor 4 Filgrastim 4 Etoposide 4 Dexamethasone 4 Cytarabine 4 Calcium Dobesilate 4 pegaspargase 3 calaspargase pegol 3 Stem Cell Transplantation 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 nelarabine 2 mogamulizumab 2 fludarabine phosphate 2 fludarabine 2 exifone 2 azathiopurine 2 Whole-Body Irradiation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡